Earnings Feed
Start Free
Home/Filings/4/0001209191-20-037956
4//SEC Filing

COLUMN GROUP III, LP 4

Accession 0001209191-20-037956

CIK 0001628171other
View on SEC.govCompany Profile

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 4:41 PM ET

Size

26.5 KB

Accession

0001209191-20-037956

Insider Transaction Report

Form 4
Period: 2020-06-17
Revolution Medicines, Inc.RVMD
COLUMN GROUP III-A, LP
10% Owner
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
Holdings

  • Common Stock

    7,977,384
Kutzkey Tim
10% OwnerOther
Transactions
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
Holdings

  • Common Stock

    7,977,384
GOEDDEL DAVID V
10% OwnerOther
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
Holdings

  • Common Stock

    7,977,384
COLUMN GROUP III GP, LP
10% OwnerOther
Transactions
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
Holdings

  • Common Stock

    7,977,384
PONOI CAPITAL, LP
10% Owner
Transactions
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
Holdings

  • Common Stock

    7,977,384
Ponoi Capital II, LP
10% Owner
Transactions
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
Holdings

  • Common Stock

    7,977,384
Ponoi II Management, LLC
10% OwnerOther
Transactions
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
Holdings

  • Common Stock

    7,977,384
COLUMN GROUP III, LP
10% Owner
Transactions
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
Holdings

  • Common Stock

    7,977,384
Ponoi Management, LLC
10% OwnerOther
Transactions
  • Other

    Common Stock

    2020-06-17+7,234→ 7,234 total(indirect: See Footnote)
  • Other

    Stock Option (Right to Buy)

    2020-02-12+36,168→ 36,168 total(indirect: See Footnote)
    Exercise: $17.00Exp: 2030-02-11→ Common Stock (36,168 underlying)
  • Other

    Stock Option (Right to Buy)

    2020-06-17+25,318→ 25,318 total(indirect: See Footnote)
    Exercise: $36.57Exp: 2030-06-16→ Common Stock (25,318 underlying)
Holdings

  • Common Stock

    7,977,384
Footnotes (11)
  • [F1]Includes 7,234 restricted stock units.
  • [F10]One thirty-sixth (1/36th) of the shares subject to the option will vest on each monthly anniversary measured from February 12, 2020, so that 100% of the shares subject to the option will be fully vested and exercisable as of the third anniversary of such date, subject to Mr. Lasky's continued service through each vesting date. Mr. Lasky's service as a director of the Issuer ceased on June 17, 2020.
  • [F11]The option was granted to Laurence Lasky, a former director of the Issuer who is a partner of the general partners of the Funds. Under the partnership agreements of the Funds, Mr. Lasky is deemed to hold the option for the economic benefit of the Funds. The reporting persons may be deemed indirect beneficial owners of the option. The reporting persons disclaim beneficial ownership of the option except to the extent of their pecuniary interest therein.
  • [F2]The restricted stock units and option were granted to Peter Svennilson, a director of the Issuer who is a managing partner of The Column Group III GP, LP ("TCG III GP") which is the general partner of The Column Group III, LP ("TCG III LP") and The Column Group III-A, LP ("TCG III-A LP"), and who is a managing partner of Ponoi Management, LLC ("Ponoi LLC") and Ponoi II Management, LLC ("Ponoi II LLC") which are the general partners of Ponoi Capital, LP ("Ponoi LP") and Ponoi Capital II, LP ("Ponoi II LP"), respectively.
  • [F3](cont.) Under the partnership agreements of TCG III LP, TCG III-A LP, Ponoi LP and Ponoi II LP (collectively, the "Funds"), Mr. Svennilson is deemed to hold the restricted stock units and option for the economic benefit of the Funds. The reporting persons may be deemed indirect beneficial owners of the restricted stock units and option. The reporting persons disclaim beneficial ownership of the restricted stock units and option except to the extent of their pecuniary interest therein.
  • [F4]Consists of 3,103,049 shares held directly by TCG III LP, 3,504,313 shares held directly by TCG III-A LP, 685,011 shares held directly by Ponoi LP and 685,011 shares held directly by Ponoi II LP.
  • [F5]The securities are directly held by TCG III LP, and indirectly held by TCG III GP, the general partner of TCG III LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. TCG III GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
  • [F6]The securities are directly held by TCG III-A LP, and indirectly held by TCG III GP, the general partner of TCG III-A LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. TCG III GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
  • [F7]The securities are directly held by Ponoi II LP, and indirectly held by Ponoi II LLC, the general partner of Ponoi II LP. The managing partners of Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. Ponoi II LLC and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
  • [F8]The securities are directly held by Ponoi LP, and indirectly held by Ponoi LLC, the general partner of Ponoi LP. The managing partners of Ponoi LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi LLC may be deemed to have voting and investment power with respect to such shares. Ponoi LLC and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
  • [F9]One thirty-sixth (1/36th) of the shares subject to the option will vest on each monthly anniversary measured from June 17, 2020, so that 100% of the shares subject to the option will be fully vested and exercisable as of the third anniversary of such date, subject to Mr. Svennilson's continued service through each vesting date.

Documents

1 file

Issuer

Revolution Medicines, Inc.

CIK 0001628171

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001668159

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:41 PM ET
Size
26.5 KB
View on SEC.gov